How to get a Mounjaro prescription online in Canada
Update log
- September 2026: Separated the authorization date from the availability date, aligned the supply status for vials and the KwikPen, merged two conflicting FAQ schema blocks into one, and removed several unsourced claims about patient experience.
With Cloudcure, you may be eligible to get Mounjaro prescribed by a licensed healthcare provider, and delivered to you for free.
Highlights
- Tirzepatide
- 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg
Convenient experience
- Expert medical advice
- Free Shipping and automatic refills
- Support when you need it
How to get Mounjaro in Canada
To get Mounjaro in Canada, you will need a prescription. You can get one by consulting with your primary care provider or through an online consultation with our licensed clinician.
Cloudcure can also conveniently deliver Mounjaro right to your door. In addition, we can also help bill your insurance provider or drug benefit provider directly for any coverage.
Is Mounjaro available in Canada?
Mounjaro has been available in Canada since November 2023. Availability depends on the format, which can include vials or an injector pen (KwikPen).
The Mounjaro KwikPen has been widely available across the country since May 2025 and continues to ship reliably. However, the vial format remains in limited supply, with recurring shortages reported since mid-2025. Patients may face challenges with access and cost, as the KwikPen is typically more expensive than the vial. Cloudcure can help you enrol in the myMounjaro and myZepbound patient-support programs. The current terms are on the program sites.
Is Mounjaro available in pre-filled pens, or only as vials in Canada?
Yes. Mounjaro is authorized in Canada in both single-dose vials and pre-filled KwikPens. As of mid-2025, the Mounjaro KwikPen is available in Canada and has quickly become the main format prescribed to patients because it is more convenient and reliable. The Mounjaro vial format is still on the market but continues to face recurring shortages in Canada, making KwikPens the more accessible option for most patients.
Health Canada's regulations require confirming your patient status to learn more. Please provide the Drug Identification Number (DIN) from your product packaging.
What is the difference between the vial and the injector pen?
Whether you choose Eli Lilly’s Mounjaro in a vial or pen format, the medication inside is the same, with Tirzepatide as the active ingredient.
Mounjaro currently ships in the following strengths in the vial format in Canada: 2.5mg, 5.0mg, 7.5mg, 10.0mg, 12.5mg, and 15.0mg.
Health Canada's regulations require confirming your patient status to learn more. Please provide the Drug Identification Number (DIN) from your product packaging.
Insurance coverage
Our solutions may be covered by your employee health or drug insurance plan.
No waiting or referrals required
Skip the waiting room and referrals. Start your health journey today.
Convenient video calls
Regular face-to-face meetings with your medical team to ask any questions or get support.
FAQ
Got questions about Mounjaro? We can help!
Yes. Mounjaro has been authorized for sale in Canada since 2022, and available by prescription since November 2023. Supply now depends on the format: the KwikPen ships reliably, while the vial has had recurring shortages since mid-2025.
Yes. The vial was the first format available in Canada, from November 2023. Eli Lilly added the Mounjaro KwikPen in May 2025, and it is now the main format prescribed to patients.
The KwikPen is a multi-dose, single-patient-use prefilled injector. Eli Lilly brought it to Canada in May 2025. It holds multiple weekly doses in one device.
According to comments published in the media from Ethan Pigott, an Eli Lilly spokesperson, Vials were only intended as a short-term solution until a multidose pen became
available to the Canadian market.
Lilly is expected to continue supporting patients already using the vial format, but the KwikPen
device will be prioritized go-forward for its supply sustainability, ease of use and multidose presentation.
No, you do not need any physical or in-person appointment to get a Mounjaro prescription at Cloudcure. However, as part of your medical evaluation, your Cloudcure team will require a video call with you after your lab work is complete. This is how your clinician checks whether Mounjaro is appropriate for you.
Not all individuals meeting this criteria may qualify for our program and other factors may be taken into consideration by the clinician including your medical history.
Once your prescription is approved, you choose how to receive it: pick it up at your local pharmacy, or have it shipped to your home. Shipping usually takes one to three business days.
Unfortunately, we cannot provide a prescription to individuals not actively enrolled in a Cloudcure program.
Generally, the following individuals may qualify for the program: Aged 18+, with a BMI of 27 to 30, and one or more metabolic conditions such as: diabetes, pre-diabetes, high cholesterol, high blood pressure, cardiovascular disease, non-alcoholic fatty liver disease, obstructive sleep apnea or PCOS. Alternatively, individuals with a BMI over 30 may also be eligible.
Not all individuals meeting this criteria may qualify for our program and other factors may be taken into consideration by the clinician, including your medical history.
Cloudcure programs combine psychology-based curriculum, effective medical treatments and ongoing support.
The process consists of a few simple steps:
- Répondez au questionnaire d’admissibilité pour vérifier si vous êtes admissible.
- Inscrivez-vous à un plan de soins pour commencer.
- Recevez votre demande d’analyse de laboratoire pour effectuer des analyses sanguines.
- Réalisez vos tests dans un laboratoire idéalement situé.
- Consultez votre fournisseur de Cloudcure afin de recevoir un plan de traitement.
- Recevez vos médicaments de manière discrète et pratique.
- Commencez votre cheminement accompagné de votre conseiller santé (optionnel).
Most of the process happens from home. You complete the eligibility quiz, receive a lab requisition, do the blood work at a lab near you, and then meet your clinician on a video call.
If you choose delivery, the lab visit is the only step that requires leaving the house. Medication ships to your address, or you can collect it at your own pharmacy instead.
Your care team stays reachable by video between appointments, so questions about dosing or side effects can be raised there.
Mounjaro may be covered by some insurance plans and employers for individuals with certain conditions. Provincial programs will vary in coverage as well. In addition, some insurance plans may require that you try other treatments before taking Mounjaro for underlying conditions.
Many insurance companies and employers may choose to provide coverage for Mounjaro. Before agreeing to cover the cost, they may ask for a confirmation or explanation from your doctor indicating its medical necessity, sometimes referred to as a pre-authorization. This approval process can take several days or weeks. For specifics regarding coverage, it's always best to contact your insurance provider directly and inquire about Mounjaro.
Cloudcure can not only help you navigate insurance coverage, but also help direct bills to your drug insurance plan.
If you are uninsured, the retail cost of Mounjaro in Canada is expected to range from $300 to $700 per month. What you pay depends on your insurance plan and any manufacturer support program you qualify for. Shipping is free with Cloudcure.
Mounjaro is approved by Health Canada for type 2 diabetes treatment at this time.
Mounjaro is designed for self-administration using a pen injector or a vial. It is generally administered once a week into the subcutaneous fatty tissue under the skin. The injection process is relatively straightforward and you can find more instructions here.
Yes, Mounjaro—like all prescription medications—comes with an expiration date printed on the packaging. To help ensure the medication remains effective, it’s important to store Mounjaro in the refrigerator. It should stay between 2°C and 8°C (36°F to 46°F) and kept out of direct light.
If needed, you can keep Mounjaro vials at room temperature (up to 30°C or 86°F) for up to 21 days, but after that, any unused medication should be discarded. For Mounjaro KwikPen, they can also be stored unrefrigerated at temperatures not to exceed 30°C for up to 30 days.
Always double-check storage and handling instructions included with your prescription for the most up-to-date guidance.
Mounjaro is a dual class medication belonging to the GLP-1 and GIP class agonists. Its active ingredient is called tirzepatide.
Mounjaro may interact with certain medications, particularly those that impact blood sugar levels. If you are taking insulin or other drugs that lower blood glucose, combining these with Mounjaro can increase the chance of low blood sugar (hypoglycemia). Your healthcare provider may need to adjust your medication doses or give you extra guidance for monitoring your blood sugar, especially when starting or changing your Mounjaro dose.
You should always let your provider know about all medications and supplements you’re taking—including prescription, over-the-counter, vitamins, and herbal products—so they can safely coordinate your care. If you notice symptoms of low blood sugar, such as shakiness, sweating, confusion, or dizziness, be sure to speak to your provider promptly.
Yes, it is. In the United States, FDA has approved tirzepatide under the brand name Zepbound, which is approved for obesity treatment. As of July 2025, this product has also been made available by Eli Lilly in accordance with Health Canada approvals.
Currently, Mounjaro is offered solely as an injectable pen. If needles aren't your preference, you can ask your healthcare provider about other options which may be equally effective and safe.
Individual patients' experiences with Mounjaro may vary. Common side effects may include nausea, diarrhea, weight-loss, decreased appetite, vomiting, constipation, indigestion, and/or abdominal pain. Many common side effects improve in the first few weeks as you get used to the medication. If symptoms persist or get worse, you should seek immediate medical care.
You should speak to your medical practitioner about side effects before you start treatment.
While many people tolerate Mounjaro well, it’s important to be aware of some less common but more serious risks. These may include:
- Pancreatitis: Inflammation of the pancreas, which can cause severe abdominal pain, nausea, or vomiting.
- Low blood sugar (hypoglycemia): Particularly if Mounjaro is used in combination with insulin or certain oral diabetes medications like sulfonylureas.
- Thyroid concerns: There is a possible risk of a rare type of thyroid tumor called medullary thyroid carcinoma (MTC). Be sure to notify your provider if you have a personal or family history of thyroid tumors.
- Kidney issues: Severe dehydration due to ongoing vomiting or diarrhea can, in rare cases, lead to kidney problems.
- Gallbladder problems: Mounjaro may increase the risk of acute gallbladder disease, with symptoms such as persistent pain in the upper right abdomen.
- Diabetic eye complications: If you have a history of diabetic retinopathy, speak to your provider before starting Mounjaro, as changes in blood sugar can sometimes worsen existing eye conditions.
- Severe digestive problems: Though uncommon, some people may experience severe stomach or intestinal symptoms.
If you experience symptoms like severe abdominal pain, persistent vomiting, vision changes, or any sign of an allergic reaction, you should contact your healthcare provider or seek emergency medical attention right away. Your clinician can discuss your individual risk profile and help decide if Mounjaro is appropriate for you.
Mounjaro may be a safe, long-term treatment for some patients under the supervision of a clinician. Your clinician will also guide you on dosage adjustments, monitoring and whether it is safe for you to gradually reduce the dosage.
Mounjaro is the first and only once-a-week medicine that activates two receptors: GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1). This increases insulin production while decreasing glucagon levels, which, in turn, decreases blood glucose levels in the body. It also reduces food intake, and slows down the speed at which your stomach digests food.
The vial is used with a short diabetic or insulin needle. How much you feel it varies from person to person, and your care team can walk through the injection technique with you on a video call.
Using a vial and syringe for Mounjaro might require a few extra steps compared to the injector pen, but it's a straightforward process. You don't need medical training to do it. With clear instructions from your pharmacist or the product insert, you can confidently and safely administer the medication yourself.
Before starting Mounjaro, it’s important to make sure it’s appropriate for you, as not everyone will be a good candidate for this medication. There are certain health conditions and risk factors where Mounjaro should be avoided:
- A personal or family history of medullary thyroid carcinoma (MTC), a rare cancer of the thyroid
Diagnosis of Multiple Endocrine Neoplasia syndrome type 2 (MEN2) - Known allergy or hypersensitivity to tirzepatide or any components in the medication
- A history of pancreatitis, or existing severe gastrointestinal diseases
Always speak with your healthcare provider and share your full medical history prior to starting Mounjaro to ensure it's a safe option for you.
Health Canada's regulations require confirming your patient status to learn more. Please provide the Drug Identification Number (DIN) from your product packaging.
What if I have other questions?
If you have any medical questions or concerns, please talk to your primary healthcare provider or a licensed medical practitioner. Please note that the information presented here is of a general nature and is not a substitute for professional medical advice, diagnosis, or treatment.
Ne remettez pas vos problèmes de santé à demain.
Avec Cloudcure, commencez à prioriser votre santé dès aujourd’hui, sans délai d’attente ni recommandation de votre médecin. Traitez vos problèmes de santé dès leur apparition, avant qu’ils ne s’aggravent.
Related reading
Stubborn weight is often driven by an underlying metabolic picture. Learn more about insulin resistance, metabolic syndrome, fatty liver disease, and PCOS and weight management.